Showing posts with label cost benefit analysis. Show all posts
Showing posts with label cost benefit analysis. Show all posts

Monday, 7 December 2015

Improving the Quality of Orthotics Services in England

"This document sets out a case for action to tackle the rising demand and variation in access and quality of services experienced by children and adults requiring orthotic care in England. It explains why it is important to improve the commissioning of services in terms of clinical and cost benefits and discusses some of the key issues affecting services currently, along with the experiences that patients and their families have had in using those services "

Improving the Quality of Orthotics Services in England
NHS England
November 2015

Read more here

Monday, 21 September 2015

Moving healthcare closer to home

"Support for providers and commissioners to make evidence-based appraisals of how the benefits compare with the costs of various approaches to move care closer to home."

Moving healthcare closer to home
Monitor
September 2015

Read more here.

Tuesday, 31 March 2015

Investing in children's mental health

"Our review of the evidence shows that for all these conditions there are interventions that are not only effective in improving outcomes but also good value for money, in some cases outstandingly so, as measured by the surplus of measurable economic benefits over the costs of intervention." 

Investing in children's mental health: A review of evidence on the costs and benefits of increased service provision
L Khan, M Parsonage, J Stubbs
Centre Forum’s Mental Health Commission, Centre for Mental Health
February 2015

Read more here.

Tuesday, 16 September 2014

Societal cost-effectiveness analysis of the 21-gene assay in early-stage breast cancer in Japan

"The 21-gene assay for women with estrogen-receptor–positive, lymph-node–negative, early-stage breast cancer is projected to be cost-effective in Japan."

Societal cost-effectiveness analysis of the 21-gene assay in estrogen-receptor–positive, lymph-node–negative early-stage breast cancer in Japan
H Yamauchi et al.
BMC Health Services Research 2014, 14:372

Read more here.

Monday, 14 April 2014

Cost benefit analysis guidance for local partnerships

"This document outlines a methodology for a cost-benefit analysis (CBA) model originally developed by New Economy, local authorities and other public sector agencies across Greater Manchester (GM). It is designed to simplify and to lower the cost of performing CBA in the context of local programmes to improve public services where analytical and research resources may be relatively limited." 

Supporting public service transformation: cost benefit analysis guidance for local partnerships
HM Treasury, Public Service Transformation Network, New Economy
April 2014

Read more here.